Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells

Cancer Research

Volumn 65, Issue 1, 2005, Pages 148-156

  Ambesi, Anthony ^a   Klein, R Matthew ^a   Pumiglia, Kevin M ^a   McKeown Longo, Paula J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTELLIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; ESTROGEN RECEPTOR BETA; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; THYMIDINE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DERMIS; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; METASTASIS; MICROVASCULATURE; PHASE TRANSITION; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; APOPTOSIS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; G1 PHASE; HUMANS; KINETICS; MICROCIRCULATION; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SKIN;

EID: 11244261710     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002;115:3861-3.
2. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003;116:3269-76.
3. Allen-Hoffman BL, Crankshaw CL, Mosher DF. Transforming growth factor b increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol 1988;8:4234-42.
4. Zhang Q, Checovich WJ, Peters DM, Albrecht RM, Mosher DF. Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid. J Cell Biol 1994;127:1447-59.
5. Vogelezang MG, Scherer SS, Fawcett JW, Ffrench-Constant C. Regulation of fibronectin alternative splicing during peripheral nerve repair. J Neurosci Res 1999;56:323-33.
6. Ohashi T, Kiehrat DP, Erickson HP. Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci U S A 1999;96:2153-8.
7. Kamiya S, Kato R, Wakabayashi M, et al. Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly. Biochemistry 2002;41:3270-7.
8. Fukai F, Mashimo M, Akiyama K, Goto T, Tanuma S, Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 1998;242:92-9.
9. Bourdoulous S, Orend G, MacKenna DA, Pasqualini R, Ruoslahti E. Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J Cell Biol 1998;143:267-76.
10. Sottile J, Hocking DC, Swiatek PJ. Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci 1998;111:2933-43.
11. Sechler JL, Schwarzbauer JE. Control of cell cycle progression by fibronectin matrix architecture. J Biol Chem 1998;273:25533-6.
12. Christopher RA, Judge SR, Vincent PA, Higgins PJ, McKeown-Longo PJ. The amino terminal matrix assembly domain of fibronectin stabilizes cell shape and prevents cell cycle progression. J Cell Sci 1999;112:3225-35.
13. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372:786-91.
14. Moro L, Venturino M, Bozzo C, et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 1998;17:6622-32.
15. Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
16. Brown LF, Guidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
17. Carnemolla B, Neri D, Castellani P, et al. Phage antibodies with pan-species recognition of the oncofetal angiogenesis marker fibronectin ED-B domain. Int J Cancer 1996;68:397-405.
18. 1 and protein kinase A. J Biol Chem 2000;275:33920-8.
19. Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002;296:2404-7.
20. 5 integrin-deficient mice. Development 1993;119:1093-105.
21. Petitclerc E, Boutaud A, Prestayko A, et al. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000;275:8051-61.
22. Kamphaus GD, Colorado PC, Panka DJ, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000;275:1209-15.
23. Maeshima Y, Colorado PC, Torre A, et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000;275:1340-8.
24. Ponce ML, Hibino S, Lebioda AM, Mochizuki M, Nomizu M, Kleinman HK. Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth. Cancer Res 2003;63:5060-4.
25. Pasqualini R, Bourdoulous S, Looivunen E, Woods VL Jr, Ruoslahti E. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med 1996;2:1197-203.
26. Yi M, Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci 2001;98:620-4.
27. Hocking DC, Sottile J, McKeown-Longo PJ. Fibronectin's III-I module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J Biol Chem 1994;269:19183-91.
28. Morla A, Zhang Z, Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature 1994;367:193-6.
29. Klein RM, Zheng M, Ambesi A, van de Water L, McKeown-Longo PJ. Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J Cell Sci 2003;116:4663-74.
30. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997;17:5598-611.
31. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-14.
32. Meadows KN, Bryant P, Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 2001;276:49298.
33. O'Carroll SJ, Hall AR, Myers CJ, Braithwaite AW, Dix BR. Quantifying adenoviral titers by spectrophotometry. BioTechniques 2000;28:408-12.
34. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol Cancer Ther 2004;3:187-97.
35. Kruman I, Guo Q, Mattson MP. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 1998;51:293-308.
36. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 2001;114:2553-60.
37. 6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci 1998;111:2189-95.
38. Mettouchi A, Klein S, Guo W, et al. Integrin-specific activation of Rac controls progress through the G([1]) phase of the cell cycle. Mol Cell 2001;8:115-27.
39. 1 phase. Biochem J 1997;326:61-8.
40. Balmanno K, Cook SJ. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 1999;18:3085-97.
41. 1 phase is controlled by Rho. Nat Cell Biol 2001;3:950-7.
42. Roovers K, Assoian RK. Effects of Rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G([1]) phase cyclin-dependent kinases. Mol Cell Biol 2003;23:4283-94.
43. Pritchard CA, Samuels ML, Bosch E, McMahon M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in the NIH 3T3 cells. Mol Cell Biol 1995;15:6430-42.
44. Lloyd AC. Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev 1998;8:43-8.
45. Cooper S, Shayman JA. Revisiting retinoblastoma protein phosphorylation during the mammalian cell cycle. Cell Mol Life Sci 2001;58:580-95.
46. Mercurius KO, Morla AO. Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly. Circ Res 1998;82:548-56.
47. 1-S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994;14:1669-79.
48. Bohmer RM, Scharf E, Assoian RK. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol Biol Cell 1996;7:101-11.
49. Huang S, Ingber DE. A discrete cell cycle checkpoint in late G([1]) that is cytoskeleton-dependent and MAP kinase (Erk)-independent. Exp Cell Res 2002;275:255-64.
50. Zhao J-H, Reiske H, Guan J-L. Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 1998;143:1997-2008.
51. Zhao J, Pestell R, Guan J-L. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 2001;12:4066-77.
52. Mercurius K, Morla A. Cell adhesion and signaling on the fibronectin 1st type III repeat; requisite roles for cell surface proteoglycans and integrins. BMC Cell Biol 2001;2:18-30.
53. Wickstrom SA, Alitalo K, Keski-Oja J. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J Biol Chem 2004;279:20178-85.
54. 1 integrins. Proc Natl Acad Sci U S A 2003;100:4766-71.
55. Rehn M, Veikkola T, Kukk-Valdre E, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A 2001;98:1024-9.
56. 4 integrins. J Immunol 2003;170:5704-11.
57. 4 Integrin signaling activates phosphatidylinositol 3-kinase and stimulates T cell adhesion to intercellular adhesion molecule-1 to a similar extent as CD3, but induces a distinct rearrangement of the actin cytoskeleton. J Immunol 2002;168:696-704.